ANCA Vasculitis International Conference Updates 2017

ANCA Vasculitis International Conference Updates 2017

By Anisha Dua, MD, MPH Assistant Professor of Medicine Program Director The University of Chicago Medicine, Rheumatology Research in ANCA vasculitis has gained significant momentum in the last decade with the discovery of new insights into disease mechanisms, targets for therapy, and it has resulted in better outcomes for patients.…...

Read more

Qualifying for Social Security Disability Benefits with Vasculitis

By Deanna Power Director of Outreach, Disability Benefits Help Email:  [email protected] Vasculitis comes in a variety of forms and severities.  While some people with the disorder experience mild, manageable symptoms, others with widespread or severe vasculitis may find it hard to work or complete daily tasks. If your vasculitis prevents…...

Read more

Pregnancy Possible for Women with Vasculitis

As treatments for vasculitis have improved, more and more younger patients are healthy enough to have children. There is little guidance to either the doctor or the Mom-to-be on what happens during pregnancy in these women. Megan E. B. Clowse, MD, MPH from Duke University and colleagues from the University…...

Read more

Trying to Understand Giant Cell Arteritis Relapse

  Giant cell arteritis (GCA) is a chronic condition with frequent relapses. A better understanding of why relapses occur might help identify patients who would benefit from longer treatment duration. Tanaz A. Kermani, MD, MS, Director of the Vasculitis Program at UCLA and others from the Vasculitis Clinical Research Consortium…...

Read more

Biomarkers Not Helpful in EGPA Treatment Decisions

Eosinophilic granulomatosis with polyangiitis (EGPA) is a disease that can be hard to manage. Certain blood tests (also known as biomarkers) have been used to follow disease activity and predict relapse. How well these markers actually work in patients hasn’t been rigorously tested. Paul A. Monach, MD, from the section…...

Read more